Skip to main content
. Author manuscript; available in PMC: 2023 Jan 15.
Published in final edited form as: Spine (Phila Pa 1976). 2022 Jan 15;47(2):99–104. doi: 10.1097/BRS.0000000000004139

Table 4:

Our estimates of Euroquol 5-dimension (EQ5D) utility based on ambulatory status in the context of other studies examining health-related quality of life in other cancer-based, spine and musculoskeletal conditions.

Study Condition Sample Size Utility
Spross et al16 Proximal humerus fracture 192 0.88
Davies et al20 Head and Neck cancer 2,065 0.87
Doherty et al21 Esophageal cancer 199 0.80
Current study Spinal metastases: Independently ambulatory 430 0.76
Versteeg et al1 Spinal metastases: Non-operative cohort 84 0.66
Current study Spinal metastases: Ambulatory with assistance 205 0.59
Versteeg et al1 Spinal metastases: operative cohort 136 0.52
Smith et al17 Adult cervical deformity 121 0.51
Miyazaki et al11 Spinal metastases: operative cohort at 12-months - 0.45
De Ruiter et al12 Spinal metastases: Presentation 113 0.44
Burgstaller et al18 Lumbar spinal stenosis pre-treatment 364 0.40
Morgen et al13 Spinal metastases: operative cohort at enrollment 69 0.28
Current study Spinal metastases: Non-ambulatory 40 0.14
Miyazaki et al11 Spinal metastases: operative cohort at enrollment 31 0.04